The Latest Breaking News from ABBV

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

Amid sky-high inflation and consecutive big rate hikes, recessionary fears are looming. We believe fundamentally sound and stable dividend-paying stocks Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and International Paper Company (IP) could be ideal investments to navigate a bear market. Read more.

The stock market is expected to remain under pressure as the Fed continues its hawkish stance to fight inflation. Moreover, the International Monetary Fund has recently warned of elevated global financial stability risk. We think fundamentally solid stocks UnitedHealth Group (UNH), Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and Dollar…

Raging inflation and the Fed’s continued rate hikes have kept the stock market under tremendous pressure. Healthcare stocks have always been considered safe haven amid market uncertainties, and we think fundamentally solid stocks AbbVie (ABBV), Pfizer (PFE), and McKesson Corporation (MCK) could be ideal buys for the long term. Read…

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Rising concerns over stubbornly-high inflation and the Fed’s commitment to bring it down to its desired level have kept equities under pressure lately. Amid increasing recessionary concerns, investing in blue-chip stocks such as Procter & Gamble (PG), AbbVie (ABBV), Pfizer (PFE), Dow (DOW), and Walgreens Boots Alliance (WBA) could help…

The stock market has been under pressure amid the high inflation and the Fed’s hawkish tilt. The Fed launched another 75 basis-point rate hike on Wednesday and indicated that it would keep increasing rates to bring down inflation to the target level. Thus, we think fundamentally solid stocks AbbVie (ABBV),…

The Fed’s continued monetary policy tightening and consequent recession fears are expected to keep the stock market under pressure in the upcoming months. However, bullish traders could keep paying with fundamentally strong stocks The Coca-Cola Company (KO), AbbVie (ABBV), and Merck & Co. (MRK). Read more….